Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC HFA 25: SCD-PROTECT
Author(s): Johann Bauersachs Added: 5 months ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more

Heart Failure

MI/ACS
AHA 23: The ORFAN Study
Author(s): Charalambos Antoniades Added: 1 year ago
AHA 23 — In this brief interview, we are joined by Prof Charalambos Antoniades (Oxford University, UK) to discuss the ORFAN trial, sponsored by the University of Oxford.ORFAN is a prospective, multicenter, observational study that collected CT scans, biological material and outcomes data to develop and validate biomarkers of cardiometabolic risk. The registry included 250000 unselected… View more

Digital Health

Prevention & Chronic Conditions
Job title: Martin Bucksbaum Distinguished University Chair, Professor and Director
Chao Gao
Chao Gao

Author

Research Area(s) / Expertise:

Intervention

 Job title: Interventional Cardiologist
Dr Chao Gao is an Interventional Cardiologist at XiJing Hospital in Xi’an, China, where he has worked since 2009. He studied medicine at The Fourth Military Medical University, earning both his Bachelor of Medicine and Master’s degree in Cardiology, and his research focuses on translational basic research and clinical trials relating to coronary artery disease and structural heart disease. View more
High TnI after OPCABG
Author(s): Hao Cui , Jinwei Zhang , Jianbo Yu , et al Added: 2 months ago

Heart Failure
Job title: Professor of Medicine
Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. In July 2016, Dr. Boden returned to the VA Boston Healthcare System to assume new duties as the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is… View more
Imag
Job title: Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS)
Prof José C Nicolau, Director of the Clinical Unit of Acute Coronary Disease of the Heart Institute - InCor / HCFMUSP, University of São Paolo, Brazil Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS), including hyperglycemia, LV remodeling, platelet reactivity, and antithrombotic therapy. He has participated in more than 80… View more
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF
Author(s): Carolyn Lam , Jeffrey Weitz Added: 2 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your… View more

Anticoagulation

Electrophysiology & Arrhythmia
AHA 23: Preventive Cardiology in 2023
Author(s): Michael Honigberg Added: 1 year ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation… View more

Guidelines & Statements

Prevention & Chronic Conditions
Daniel JFM Thuijs
Research Area(s) / Expertise:
Dr Daniel Thuijs, MD, currently works as a PhD-fellow at the Department of Cardiothoracic Surgery, Erasmus MC. He will start his Residency in Cardiothoracic surgery in October '19. Daniel is involved in research regarding Cardiothoracic surgery and Cardiology. Currently, his main projects are, among others, (i) the "SYNTAX Extended Survival study" (10-year survival follow-up on patients (n=1800)… View more